XJPX
2540
Market cap304mUSD
Jul 29, Last price
3,265.00JPY
1D
0.00%
1Q
6.35%
Jan 2017
73.86%
Name
Yomeishu Seizo Co Ltd
Chart & Performance
Profile
Yomeishu Seizo Co., Ltd. produces and sells herbal liqueurs and pharmaceutical products in Japan, Hong Kong, Malaysia, Singapore, and Taiwan. It offers Yomeishu, an herbal liqueur; ginger, ginseng, honey, and medicinal liqueur; fruit and herbs liqueur; Kanomori and Kanoshizuku gin; and craft gin cocktail products. The company also provides Yomeishu cough drops; Yomeishu Seizo Amazake; Herb-no-Megumi; Ururu vinegar drinks; ginger black vinegar drinks; and dilution type black vinegar drinks. In addition, it offers Koken Seisai designated quasi-pharmaceutical and health products through the mail order site www.yomeishu-online.jp. Further, the company operates CLASUWA, a commercial complex; rents/leases real estate properties; manages restaurants and shops; and generates, supplies, and sells electricity through natural energy. Yomeishu Seizo Co., Ltd. was incorporated in 1923 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
Income | |||||||||
Revenues | 10,242,250 -3.80% | 10,647,235 0.66% | |||||||
Cost of revenue | 9,546,482 | 9,655,330 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 695,768 | 991,905 | |||||||
NOPBT Margin | 6.79% | 9.32% | |||||||
Operating Taxes | 426,971 | 453,205 | |||||||
Tax Rate | 61.37% | 45.69% | |||||||
NOPAT | 268,797 | 538,700 | |||||||
Net income | 952,820 -6.64% | 1,020,603 7.44% | |||||||
Dividends | (758,957) | (553,593) | |||||||
Dividend yield | 2.92% | 2.15% | |||||||
Proceeds from repurchase of equity | (266) | 599,749 | |||||||
BB yield | 0.00% | -2.33% | |||||||
Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 1,799,551 | 1,728,216 | |||||||
Net debt | (39,575,880) | (37,400,985) | |||||||
Cash flow | |||||||||
Cash from operating activities | 667,517 | 1,748,376 | |||||||
CAPEX | (2,492,000) | (386,624) | |||||||
Cash from investing activities | 2,313,757 | (1,451,940) | |||||||
Cash from financing activities | (760,146) | (554,767) | |||||||
FCF | (2,457,993) | 743,391 | |||||||
Balance | |||||||||
Cash | 8,154,876 | 8,933,985 | |||||||
Long term investments | 31,421,004 | 28,467,000 | |||||||
Excess cash | 39,063,768 | 36,868,623 | |||||||
Stockholders' equity | 2,688,407 | 47,304,099 | |||||||
Invested Capital | 45,754,115 | 7,186,325 | |||||||
ROIC | 1.02% | 7.38% | |||||||
ROCE | 1.31% | 2.11% | |||||||
EV | |||||||||
Common stock shares outstanding | 13,828 | 13,808 | |||||||
Price | 1,881.00 0.70% | 1,868.00 6.38% | |||||||
Market cap | 26,011,226 0.85% | 25,792,929 6.55% | |||||||
EV | (13,564,654) | (11,608,056) | |||||||
EBITDA | 1,263,349 | 1,505,006 | |||||||
EV/EBITDA | |||||||||
Interest | 24,069 | 17,430 | |||||||
Interest/NOPBT | 3.46% | 1.76% |